Reporting Period: February 7–24, 2026
The AeroClenz Chief Medical Officer periodically reviews publicly available infectious disease surveillance reports from organizations such as the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and European Centre for Disease Prevention and Control (ECDC).
These summaries are intended to provide general awareness of global infectious disease activity relevant to international travel, healthcare systems, and high-traffic indoor environments.
This information is provided for situational awareness only and does not constitute medical advice.
Key Takeaways
For the period of February 7–24, 2026, several notable global infectious disease trends emerged:
- Measles continues to present significant operational challenges due to its high transmissibility
- Seasonal respiratory viruses remain the primary day-to-day burden across multiple regions
- Mpox cases in Europe show ongoing transmission within defined networks
- Cholera activity persists across multiple countries, particularly in resource-limited settings
- Zoonotic and high-consequence pathogens remain under active global surveillance
Measles Activity: High Impact per Case
Measles remains one of the most operationally disruptive infectious diseases due to its ability to spread rapidly following a single exposure event.
As of February 19, 2026, the CDC reports 982 confirmed measles cases in the United States, with approximately 89 percent associated with outbreaks.
Recent reported cases include exposures at:
- Ave Maria University (Florida)
- St. Petersburg Catholic High School (Florida)
The Pan American Health Organization (PAHO) has also issued warnings regarding increasing measles activity across the Americas, emphasizing the importance of surveillance and vaccination coverage.
The potential for rapid spread, combined with the complexity of contact tracing and exposure management, continues to make measles a key public-health consideration in travel and congregate settings.
Seasonal Respiratory Viruses: Ongoing Operational Burden
Respiratory viruses remain the most consistent source of healthcare and operational strain globally.
According to WHO surveillance:
- Influenza positivity remains just above 15 percent globally (week 6)
- SARS-CoV-2 activity remains comparatively low
CDC FluView data (week ending February 14) indicates:
- Continued influenza activity across the United States
- Regional variation in dominant influenza strains (A vs B)
The ECDC reports:
- Elevated respiratory illness consultations across much of the EU/EEA
- Influenza activity declining but still elevated
- RSV circulation ongoing
- SARS-CoV-2 activity lower relative to influenza and RSV
These trends suggest continued pressure on healthcare systems and workforce availability across multiple regions.
Mpox in Europe: Clade I Signals and Surveillance
Mpox activity continues to be monitored in Europe, particularly with respect to clade I variants.
As of February 17, 2026, the ECDC reports:
- 255 mpox cases across 10 EU/EEA countries since January 1, 2026
- Evidence of ongoing transmission within defined social and sexual networks
- Risk assessed as moderate for certain populations and low for the general population
Additionally, WHO reporting referenced by ECDC notes the identification of a recombinant strain involving clade Ib and clade IIb, highlighting the importance of genomic surveillance in tracking viral evolution.
Cholera: Persistent Multi-Country Activity
Cholera remains a significant public-health concern in multiple regions, particularly where water, sanitation, and hygiene (WASH) systems are under strain.
According to WHO Update #34:
- 182 associated deaths
- A 20 percent increase compared to the previous month
- Cases reported across 19 countries
These trends underscore the continued importance of monitoring infectious disease risks in regions experiencing infrastructure challenges.
Zoonotic and High-Consequence Pathogens
Several zoonotic and high-consequence pathogens remain under active surveillance.
ECDC reports:
- A confirmed human H5N1 case in Cambodia (February 14), associated with exposure to infected poultry
- A human A(H10N3) case in China (Guangdong), with no evidence of human-to-human transmission
For Nipah virus:
WHO reports limited case counts in:
- Bangladesh (linked to date palm sap exposure)
- India (including healthcare-associated cases)
In both contexts, the risk of broader international spread remains low based on current assessments, though continued monitoring is emphasized given the potential severity of these pathogens.
Additional Diseases of Ongoing Interest
Other infectious disease trends noted during this period include:
- Measles (global and Americas): ongoing outbreaks and immunity gaps
- Influenza and RSV: continued circulation with regional variability
- Mpox (Europe): sustained monitoring of clade I variants and recombinant strains
- Cholera: ongoing multi-country activity
- Zika virus: no acute surge during this period, but continued classification as a persistent arboviral risk
Summary
The global infectious disease landscape for mid-February 2026 is characterized by:
- Continued measles resurgence with high impact per exposure event
- Persistent respiratory virus activity as the primary operational burden
- Regional mpox activity with evolving viral characteristics
- Sustained cholera transmission in multiple countries
- Ongoing monitoring of zoonotic and high-consequence pathogens
Public-health surveillance agencies continue to monitor these developments and publish updates as new information becomes available.
Sources referenced in this summary include the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC), and peer-reviewed literature, including the Journal of Travel Medicine.
To learn more about AeroClenz, visit www.aeroclenz.com. Follow AeroClenz on social media for updates on research and technology developments.
LinkedIn: https://www.linkedin.com/company/aeroclenz
Facebook: https://www.facebook.com/AeroClenz
Instagram: https://www.instagram.com/aeroclenz_